As of 4:02pm ET
| -0.22 / -0.51%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 43.45, with a high estimate of 50.60 and a low estimate of 32.00. The median estimate represents a +0.68% increase from the last price of 43.16.
The current consensus among 33 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.